918
Participants
Start Date
September 3, 2018
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
10d bismuth quadruple therapy
rabeprazole 20 mg b.i.d. plus tripotassium dicitrate bismuthate 300 mg, tetracycline 500 mg and metronidazole 250 mg q.i.d. for 10 days
14d hybrid therapy
a dual regimen with rabeprazole 20 mg and amoxicillin 1 g b.i.d. for 7 days followed by a quadruple regimen with rabeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg and metronidazole 500 mg b.i.d. for 7 days
14D high-dose dual therapy
rabeprazole 20 mg and amoxicillin 750 mg q.i.d. for 14 days
Kaohsiung Veterans General Hospital, Kaohsiung City
Kaohsiung Veterans General Hospital.
OTHER